Dr. Rishi Singh

@drrishisingh

Staff Physician, Retina Specialist, Cole Eye Institute, , retina, AMD, diabetic retinopathy, retinal detachments, ophthalmology

Cleveland, OH
Vrijeme pridruživanja: veljača 2011.

Tweetovi

Blokirali ste korisnika/cu @drrishisingh

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @drrishisingh

  1. 5. velj

    How do define and address treatment failures in AMD? 📺 Watch my interview with Dr. Nathan Steinle at the Retina 2020 meeting 📲

    , , i još njih 5
    Poništi
  2. proslijedio/la je Tweet
    3. velj

    Calling all specialists 📣 Listen to & Dilsher Dhoot, MD discuss current barriers to care of patients with neovascular age-related macular degeneration in this . Earn 0.25 credits today -->

    Poništi
  3. proslijedio/la je Tweet
    3. velj

    This is your last chance to review advances in diagnostic imaging of retinal disorders & innovations in the surgical treatment of retinal disease! Make sure you complete this activity soon >>

    Poništi
  4. proslijedio/la je Tweet
    2. velj

    Watch this video on the management of diabetic retinopathy! Earn 0.25 credits by participating over on -->

    Poništi
  5. proslijedio/la je Tweet
    31. sij

    Authors note "While gene expression profiling testing is an important prognostic tool for patients with posterior uveal melanoma, tumor size is an important variable that seems to enhance prognostic discrimination."

    Poništi
  6. proslijedio/la je Tweet
    31. sij

    Authors : Cataract surgery beneficial in patients with diabetic retinopathy w/o macular pathology. But "visual acuity before surgery & severity of diabetic retinopathy can limit desired operative outcomes."

    Poništi
  7. proslijedio/la je Tweet
    31. sij

    This video was filmed during with Drs. , , & Carl Regillo examining new evidence regarding the treatment of proliferative & nonproliferative diabetic retinopathy >>

    Poništi
  8. 27. sij

    Great weekend learning from my fellow faculty members and teaching fellows at the 2020 Retina Fellows Forum in Chicago 📚 In 2007 I was an attendee and glad I was able to contribute back to this fine program.

    , , i još njih 7
    Poništi
  9. proslijedio/la je Tweet
    25. sij

    Discussing the PANORAMA study, discussing efficacy of treating severe NPDR without DME and advocates for use of anti-VEGF in patients with severe NPDR for 2 step regression. would like to see clarity with 5, 10 year data.

    Poništi
  10. proslijedio/la je Tweet
    25. sij

    Great presentation by showing the efficacy of artificial intelligence and deep learning to determine abnormalities on fundus photos and OCT. Can now predict age, gender, diabetes status, and blood pressure.

    Poništi
  11. proslijedio/la je Tweet
    24. sij

    Now discussing port delivery systems to deliver ranibizumab and gene therapy as different ways to have sustained anti-VEGF concentrations into the eye.

    Poništi
  12. proslijedio/la je Tweet
    24. sij

    This wonderful panel of faculty presented, "Retina360: Advances in the Management of Retinal Disease." Thank you for another successful seminar, , , Dean Eliott, MD, Sumit Sharma, MD, Sophie J. Bakri, MD, and Dilsher S. Dhoot, MD!

    Poništi
  13. 23. sij

    NEW POST❗️ Beovu is out and finally we have some very preliminary patient results to share. I recently wrote about why Beovu would potentially be superior to what we have available - for the article. 💉

    Poništi
  14. proslijedio/la je Tweet
    22. sij

    Hope you can join us

    Poništi
  15. 22. sij

    Our study was just published on long term outcomes of patients treated with Eplerenone for the treatment of chronic central serous chorioretinopathy. ⁦⁩ ⁦

    Poništi
  16. proslijedio/la je Tweet
    21. sij

    A special thank you to , , and Judy Kim, MD for putting on a great seminar this morning!

    Poništi
  17. 18. sij

    Definitely not the truth about sunglasses and the ocular system. Be careful what you read on the internet these days. ⁦⁩ ⁦⁦⁩ Sunglasses are killing you - Veritas - Medium

    Poništi
  18. 16. sij

    Excellent discussion on how we manage our anti VEGF patients long term.

    Poništi
  19. 16. sij

    Thanks Rajesh. This was a difficult study given the lack of literature in the area but the conclusions are solid. Glad people can learn from this analysis.

    Poništi
  20. proslijedio/la je Tweet
    4. sij

    Examine classification criteria for diabetic retinopathy to better understand its relevance to disease management strategies in this activity & earn 0.25 credits! Participate today >>

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·